Affiliation:
1. The University of Texas MD Anderson Cancer Center,Texas,United States,77033,
Abstract
Glycoproteins or glycosylated proteins are carbohydrates (oligosaccharide
chains or glycan’s) linked proteins and execute important functions in the biological
systems, such as embryonic development, cell-to-cell recognition, adhesion, pathogen
identification and immune functions. It is evident that the alteration of glycoproteins in
cells are associated with a number of human diseases, including cancer, rheumatoid
arthritis, inflammatory diseases as well as immunodeficiency diseases. Recent
advances in modern technologies in cancer treatment are promising. However,
researchers and clinicians are still searching for appropriate biomarkers for the early
detection and management of patients with cancer. Altered glycoprotein levels are
associated with critical events in cancer pathogenesis and progression. Also, abnormal
glycosylation of protein is a common regulatory event in carcinogenesis, therefore,
aberrant glycosylation could act as a promising resource in identifying a cancer
biomarker for diagnosis and monitoring of the progression of patients with cancers.
This chapter summarizes the major clinically approved glycoproteins utilized for
screening, diagnosis, and monitoring of the treatment response of patients with cancers.<br>
Publisher
BENTHAM SCIENCE PUBLISHERS
Reference227 articles.
1. Siegel R.L.; Miller K.D.; Jemal A.; Cancer statistics, 2020. CA Cancer J Clin 2020,70(1),7-30
2. Vasan N.; Baselga J.; Hyman D.M.; A view on drug resistance in cancer. Nature 2019,575(7782),299-309
3. Stowell S.R.; Ju T.; Cummings R.D.; Protein glycosylation in cancer. Annu Rev Pathol 2015,10(1),473-510
4. Pan S.; Brentnall T.A.; Chen R.; Glycoproteins and glycoproteomics in pancreatic cancer. World J Gastroenterol 2016,22(42),9288-9299
5. Crumpton M.J.; Glycoproteins in relation to cell differentiation and malignancy. Prog Clin Biol Res 1982,102 pt A,359-370